50
Participants
Start Date
February 28, 2025
Primary Completion Date
January 15, 2026
Study Completion Date
May 15, 2026
Experimental ureteric stent with specially shaped side-holes that prevent stagnation points (i.e., areas of low flow that cause particles to settle and E&B)
Kidney stone patients and Oncology patients admitted to either the University Hospital Southampton (UHS) or University College London Hospital (UCLH) for management of kidney stones or for the management of urine drainage in ureter will have a novel ureteric stent instead of their planned conventional stent. The novel stent will be removed after 4 weeks (kidney stone patients) or 25 weeks (oncology patients). Recruitment to the cohort of oncology patients will only commence once the results for kidney stones patients have been reviewed.
Qualitative interview
Kidney stone patients, Oncology patients and doctors will be interviewed about their experience of having a stent, or their experience in managing patients with a stent.
University Hospital Southampton NHS Foundation Trust
OTHER
National Institute for Health Research, United Kingdom
OTHER_GOV
University College London Hospitals
OTHER
University of Southampton
OTHER